Nektar Therapeutics (NKTR)
$19.43 0.51 (2.56%)
16:52 EST NKTR Stock Quote Delayed 15 Minutes
Previous Close $19.43
Market Cap 3.33B
PE Ratio -24.29
Volume (Avg. Vol.) 1.99M
Day's Range 19.30 - 19.98
52-Week Range 15.64 - 47.11
Dividend & Yield N/A (N/A)
NKTR Stock Predictions, Articles, and Nektar Therapeutics News
- From InvestorPlace
- From the Web
While the markets have roared higher in 2019, these stocks have been crashing. But some of them could rebound soon.
Uncertainty is a constant risks for biotech stocks. Which ones matter? Some are down so much investors cannot ignore them now.
Stock charts of VRTX, NKTR and SYMC are going to end the trading week knocking on the door of major moves.
All-American U.S. stocks like Foot Locker, Copart and Snapchat are on the mend for all the right reasons. here are the charts to watch.
As we move into the weekend, the stock charts of AOS, NKTR and WAT should be on your radar.
Sellers dominated the trading action on Nektar stock after its preliminary clinical results. Over-reaction or justified selling? The market simply did not understand the results, hurting the NKTR stock price.
Bristol-Myers Squibb Company (BMY) shares were sliding as the company's collaboration cancer drug with Nektar Therapeutics (NKTR) did not impress investors.
Nektar Therapeutics (NKTR) took a heavy hit on Monday following the release of preliminary results from a recent clinical trial.
Nektar Therapeutics pulled back in recent weeks, and that is a good thing. Valuations are stretched, but the upside in NKTR stock is high if management delivers.
3 Stocks to Watch on Friday: Alphabet Inc (GOOG, GOOGL), Nektar Therapeutics (NKTR) and Solaredge Technologies Inc (SEDG)
Alphabet Inc (GOOG,GOOGL) is fixing latency issues with Google Home Max, while Nektar Therapeutics (NKTR) and Solaredge Technologies Inc (SEDG) reported earnings.
In the end, the Dow lost a fraction, the S&P gave back 0.2%, the Nasdaq gained a fraction and the Russell 2000 finished the day 0.5% lower.
The overall ratings of 16 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
Analysts Offer Insights on Healthcare Companies: Pieris Pharmaceuticals (NASDAQ: PIRS) and Nektar Therapeutics (NASDAQ: NKTR)
From Analyst Ratings
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Pieris Pharmaceuticals (PIRS – Research Report) and Nektar Therapeutics (NKTR – Research Report) with bullish sentiments. Pieris Pharmaceuticals (PIRS) William Blair analyst Matt Phipps maintained a Buy rating on Pieris Pharmaceuticals today. The company’s shares closed last
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!